Bollerslev J - Search Results

1

Hormonal dysfunction is frequent in cancer survivors treated with radiotherapy to the head and neck region.

Seland M, Bjøro T, Furre T, Schreiner T, Bollerslev J, Fosså SD, Loge JH, Holte H, Kiserud CE. Seland M, et al. Among authors: bollerslev j. J Cancer Surviv. 2015 Dec;9(4):630-40. doi: 10.1007/s11764-015-0439-x. Epub 2015 Mar 7. J Cancer Surviv. 2015. PMID: 25750158

2

Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.

Bjøro K, Brandsaeter B, Wiencke K, Bjøro T, Godang K, Bollerslev J, Schrumpf E. Bjøro K, et al. Among authors: bollerslev j. Scand J Gastroenterol. 2003 Mar;38(3):320-7. Scand J Gastroenterol. 2003. PMID: 12737449

3

Growth hormone substitution increases gene expression of members of the IGF family in cortical bone from women with adult onset growth hormone deficiency--relationship with bone turn-over.

Ueland T, Odgren PR, Yndestad A, Godang K, Schreiner T, Marks SC, Bollerslev J. Ueland T, et al. Among authors: bollerslev j. Bone. 2003 Oct;33(4):638-45. doi: 10.1016/s8756-3282(03)00240-0. Bone. 2003. PMID: 14555269 Clinical Trial.

4

Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial.

Bollerslev J, Hallén J, Fougner KJ, Jørgensen AP, Kristo C, Fagertun H, Gudmundsen O, Burman P, Schreiner T. Bollerslev J, et al. Eur J Endocrinol. 2005 Sep;153(3):379-87. doi: 10.1530/eje.1.01971. Eur J Endocrinol. 2005. PMID: 16131600 Clinical Trial.

5

Positive effects of a physiological dose of GH on markers of atherogenesis: a placebo-controlled study in patients with adult-onset GH deficiency.

Bollerslev J, Ueland T, Jørgensen AP, Fougner KJ, Wergeland R, Schreiner T, Burman P. Bollerslev J, et al. Eur J Endocrinol. 2006 Apr;154(4):537-43. doi: 10.1530/eje.1.02125. Eur J Endocrinol. 2006. PMID: 16556716 Clinical Trial.

6

Serum GH and IGF-I are significant determinants of bone turnover but not bone mineral density in active acromegaly: a prospective study of more than 70 consecutive patients.

Ueland T, Fougner SL, Godang K, Schreiner T, Bollerslev J. Ueland T, et al. Among authors: bollerslev j. Eur J Endocrinol. 2006 Nov;155(5):709-15. doi: 10.1530/eje.1.02285. Eur J Endocrinol. 2006. PMID: 17062887

7

Preoperative octreotide treatment in newly diagnosed acromegalic patients with macroadenomas increases cure short-term postoperative rates: a prospective, randomized trial.

Carlsen SM, Lund-Johansen M, Schreiner T, Aanderud S, Johannesen O, Svartberg J, Cooper JG, Hald JK, Fougner SL, Bollerslev J; Preoperative Octreotide Treatment of Acromegaly study group. Carlsen SM, et al. Among authors: bollerslev j. J Clin Endocrinol Metab. 2008 Aug;93(8):2984-90. doi: 10.1210/jc.2008-0315. Epub 2008 May 20. J Clin Endocrinol Metab. 2008. PMID: 18492760 Clinical Trial.

8

Associations between body composition, circulating interleukin-1 receptor antagonist, osteocalcin, and insulin metabolism in active acromegaly.

Ueland T, Fougner SL, Godang K, Lekva T, Schurgers LJ, Scholz H, Halvorsen B, Schreiner T, Aukrust P, Bollerslev J. Ueland T, et al. Among authors: bollerslev j. J Clin Endocrinol Metab. 2010 Jan;95(1):361-8. doi: 10.1210/jc.2009-0422. Epub 2009 Oct 30. J Clin Endocrinol Metab. 2010. PMID: 19880791

9

Body composition, endocrine and metabolic profiles in adults with Prader-Willi syndrome.

Sode-Carlsen R, Farholt S, Rabben KF, Bollerslev J, Schreiner T, Jurik AG, Christiansen JS, Höybye C. Sode-Carlsen R, et al. Among authors: bollerslev j. Growth Horm IGF Res. 2010 Jun;20(3):179-84. doi: 10.1016/j.ghir.2009.12.004. Epub 2010 Mar 3. Growth Horm IGF Res. 2010. PMID: 20199883 Clinical Trial.

10

Favorable long-term effects of growth hormone replacement therapy on quality of life, bone metabolism, body composition and lipid levels in patients with adult-onset growth hormone deficiency.

Jørgensen AP, Fougner KJ, Ueland T, Gudmundsen O, Burman P, Schreiner T, Bollerslev J. Jørgensen AP, et al. Among authors: bollerslev j. Growth Horm IGF Res. 2011 Apr;21(2):69-75. doi: 10.1016/j.ghir.2011.01.001. Epub 2011 Feb 3. Growth Horm IGF Res. 2011. PMID: 21295507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

342 results

Search Page